Health Condition 1: - Health Condition 2: C180- Malignant neoplasm of cecum Health Condition 3: C182- Malignant neoplasm of ascending colon Health Condition 4: C181- Malignant neoplasm of appendix Health Condition 5: C187- Malignant neoplasm of sigmoid colon Health Condition 6: C184- Malignant neoplasm of transverse colon Health Condition 7: C183- Malignant neoplasm of hepatic flexure Health Condition 8: C185- Malignant neoplasm of splenic flexure Health Condition 9: C186- Malignant neoplasm of
Conditions
Interventions
Intervention1: Sugammadex: Dose-2-4mg/kg body weight based on TOF COUNT.
Given intravenously once after completion of surgery and return of spontaneous breathing.
Return of Bowel activity analysed pos
Sponsors
Priyanka Kumari
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients with ASA physical status I, II, or III. 2 Patients aged 18 years and above of either sex undergoing laparoscopic colorectal surgery. 3 Patients able to comprehend and willing to participate. 4 Patients scheduled for neuromuscular blockade reversal with either Neostigmine-glycopyrrolate or Sugammadex.
Exclusion criteria
Exclusion criteria: 1 Patients who refuse to participate. 2 Patients with known hypersensitivity to neostigmine, glycopyrrolate, or sugammadex. 3 Patients with severe renal or hepatic dysfunction. 4 Patients with pre-existing bowel motility disorders. 5 Patients with significant cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Return of Bowel motility 24 hour postoperatively.Timepoint: Return of Bowel motility 24 hour postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first oral intake. Evaluate postoperative nausea and vomiting. Assess total opioid consumption within 24hrs postoperatively.Timepoint: first 24 hour postoperatively. | — |
Countries
India
Contacts
Public ContactProf Dr Vinod Kumar Verma
Indira Gandhi Institute of Medical Sciences,Patna.
Outcome results
None listed